The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to the Securities and Exchange Commission (SEC)
by insider Patton John Stuart since year 2005.
The trader's CIK number is 1247653.
At the time of this reporting, Patton John Stuart is the Chief Scientific Officer of
Halozyme Therapeutics Inc
(stock ticker symbol HTI).
Note that in the past PATTON JOHN STUART also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by Patton John Stuart since 2005.
Trade Date
Symbol
Company Name (Issuer)
Trade Type
Shares
Price ($)
Value ($)
2007-10-16
HALO
Halozyme Therapeutics Inc
Sale
15,000
9.02
135,300
2007-10-09
HALO
Halozyme Therapeutics Inc
Sale
15,000
8.70
130,453
2007-10-02
HALO
Halozyme Therapeutics Inc
Sale
15,000
8.90
133,425
2007-09-25
HALO
Halozyme Therapeutics Inc
Sale
15,000
8.94
134,172
2007-09-18
HALO
Halozyme Therapeutics Inc
Sale
17,471
8.89
155,363
2007-07-10
HALO
Halozyme Therapeutics Inc
Sale
20,000
9.78
195,573
2007-06-26
HALO
Halozyme Therapeutics Inc
Sale
8,200
8.99
73,730
2007-06-26
HALO
Halozyme Therapeutics Inc
Sale
11,800
8.68
102,404
2007-06-19
HALO
Halozyme Therapeutics Inc
Sale
20,000
10.28
205,616
2007-06-12
HALO
Halozyme Therapeutics Inc
Sale
20,000
10.09
201,863
2007-05-29
HALO
Halozyme Therapeutics Inc
Sale
20,000
10.31
206,107
2007-05-23
HALO
Halozyme Therapeutics Inc
Sale
15,000
10.52
157,800
2007-05-22
HALO
Halozyme Therapeutics Inc
Sale
20,000
10.53
210,557
2007-04-18
HTI
Halozyme Therapeutics Inc
Sale
25,000
9.13
228,369
2007-04-11
HTI
Halozyme Therapeutics Inc
Sale
25,000
8.61
215,312
2007-04-04
HTI
Halozyme Therapeutics Inc
Sale
25,000
8.35
208,750
2007-03-28
HTI
Halozyme Therapeutics Inc
Sale
25,000
8.40
209,960
2007-03-21
HTI
Halozyme Therapeutics Inc
Sale
25,000
8.61
215,282
2007-03-14
HTI
Halozyme Therapeutics Inc
Sale
16,400
8.02
131,528
2007-03-15
HTI
Halozyme Therapeutics Inc
Sale
8,600
8.00
68,800
2007-01-26
NKTR
Nektar Therapeutics
Option Exercise
14,000
13.29
186,060
2007-01-05
NKTR
Nektar Therapeutics
Option Exercise
1,000
14.52
14,520
2007-01-26
NKTR
Nektar Therapeutics
Option Exercise
14,000
13.29
186,060
2007-01-05
NKTR
Nektar Therapeutics
Option Exercise
1,000
14.52
14,520
2006-05-15
NKTR
Nektar Therapeutics
Sale
1,633
20.21
33,002
2006-03-07
NKTR
Nektar Therapeutics
Sale
3,859
19.80
76,390
2006-01-27
NKTR
Nektar Therapeutics
Sale
20,000
22.00
440,000
2006-01-18
NKTR
Nektar Therapeutics
Option Exercise
34,645
19.32
669,341
2006-01-19
NKTR
Nektar Therapeutics
Option Exercise
23,355
19.37
452,386
2006-01-13
NKTR
Nektar Therapeutics
Sale
20,000
20.05
401,000
2005-05-10
NKTR
Nektar Therapeutics
Sale
1,750
14.47
25,322
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Patton John Stuart
(Chief Scientific Officer of Halozyme Therapeutics Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.
